DRD2 and schizophrenia: In schizophrenia patients and models, low dopamine activity in the PFC was assumed to cause cognitive symptoms, whereas increased D2 dopamine receptor densities were detectable (Seeman and Niznik, 1990; Brisch et al., 2014).